The Andromeda Study.Predictive Value of Combined Criteria to Tailor Breast Cancer Screening.

CompletedOBSERVATIONAL
Enrollment

26,600

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

March 31, 2018

Study Completion Date

March 31, 2018

Conditions
Breast Cancer
Trial Locations (4)

10123

S.C.D.O. Epidemiologia dei Tumori - Azienda Ospedaliera S. Giovanni Battista di Torino, Turin

10126

Senologia Di Screening - Sscvd, Turin

13100

ASL Vercelli, Vercelli

13876

ASL Biella, Biella

All Listed Sponsors
collaborator

Azienda Sanitaria Locale di Biella

OTHER

collaborator

Azienda Sanitaria Locale di Vercelli

OTHER

collaborator

Fondazione Edo Ed Elvo Tempia Valenta

OTHER

collaborator

Associazione Italiana per la Ricerca sul Cancro

OTHER

lead

Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte

OTHER

NCT02618538 - The Andromeda Study.Predictive Value of Combined Criteria to Tailor Breast Cancer Screening. | Biotech Hunter | Biotech Hunter